Showing results for:

Guyana can tap multi-million-dollar LNG opportunities with Gas-to-Energy project – MP

Guyanese Member of Parliament (MP), Jermaine Figueira believes the imminent Gas-to-Energy Project will be a game-changer for the South American producer as it is intended to provide a reliable and affordable source of energy for domestic consumption while facilitating...

Guyana gov’t disagrees with Court on Exxon’s insurance obligations for offshore operations

The Guyana government and the Environmental Protection Agency (EPA) are set to appeal a recent Guyana Supreme Court ruling that determined that the EPA and ExxonMobil affiliate, Esso Exploration and Production Guyana Limited (EEPGL), breached the terms of the...

Technip Energies First Quarter 2023 Financial Results

Solid first quarter; consistent with full year 2023 objectives Adjusted revenue of €1,407 million, Adjusted recurring EBIT margin of 7.6% 10% year-over-year growth in Adjusted net profit of €80 million Preparing future core with the creation of Rely – a new integrated...

Innate Pharma Highlights Clinical Abstracts Selected for ASCO 2023 Annual Meeting

Oral presentation on SAR’579 / IPH6101, a potential first-in-class NKp46/CD16-based NK cell engager targeting CD123; SAR’579 / IPH6101 is ANKET® platform lead asset and under development by partner Sanofi Two Trial in Progress posters including monalizumab in non-small cell lung...

Stabroek Block produced 378,000 bpd in first quarter of 2023

ExxonMobil produced 34.05 million barrels of crude in the first quarter of 2023 from the Liza projects offshore Guyana, at 378,340 barrels per day (bpd). Output peaked at 408,860 bpd.  Liza Phase 1 produced 13.598 million barrels at 151,090 bpd....

Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in...

This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a Phase 3 clinical trial, UZEDY demonstrated up to 80% reduction in risk of schizophrenia relapse versus placebo1 UZEDY is a...

Enhanced oil and gas exhibit unveiled at Guyana’s National Museum; allows for 3D view onboard FPSO 

Oil has become an important part of Guyana’s history, preserved and on view at the country’s National Museum as Stabroek Block operator ExxonMobil relaunched the new and improved oil and gas exhibit.  While many will not be able to travel...

MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)

- Results from the Phase 2 L-MIND study were highlighted as a late-breaking oral presentation at the American Association for Cancer Research Annual Meeting 2023BOSTON & WILMINGTON, Del.--(BUSINESS WIRE)--MorphoSys U.S. Inc., a fully owned subsidiary of MorphoSys AG (FSE:...

Guyana will be “gift that keeps on giving” – Analyst 

Guyana’s value to ExxonMobil will be felt for decades to come, according to an Analyst at Seeking Alpha, a crowd-sourced content service provider that publishes news on financial markets.  In his latest piece on April 12, the analyst examined Exxon’s...

Athersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX) today announced financial results for the three and 12 months ended December 31, 2022, and provided a business update. Fourth Quarter 2022 and Recent Corporate and Operational Highlights Largely completed the company’s restructuring initiative with the...

Latest News

GranMorgu FPSO construction hits 27% as Suriname targets first oil by 2028

Construction of the floating production, storage and offloading (FPSO) platform for Suriname’s GranMorgu project has reached 27%, state oil...